Australia growth equity solutions

Get the growth capital you need in Australia.

Acclime’s market experts guide companies through critical growth stages, combining rigorous analysis with a real‑world understanding of investor appetite to bring clarity and confidence to capital‑markets decisions.

Why trust Acclime?

We leverage in-house expertise and external networks to make sure governance is sound and structures are in place to facilitate responsible capital raising for your business, cautiously advising those requiring funding in the research & development or exploration phases of growth.

Valuable insights

Acclime leverages decades of experience across our portfolio of small cap and other listed companies to offer comment and insight in every context that counts for capital raising and IPO.

Actionable intelligence

We provide access to intelligence on every financial question impacting your journey to revenue generation with measured optimism, caution when required and insights communicated on demand and at monthly board meetings.

Quality reporting

We work closely with directors, auditors and other stakeholders in the process. We are steeped in the compliance frameworks for reporting on listed and unlisted public companies, bringing quality and security to any filing.

Essential growth capital services

Put the right capital behind your growth strategy.

From pre‑revenue to pre‑IPO and emerging, we bring decades of experience in growth stages, with particular strength in the strategy and governance requirements of listed companies in the biotech, fintech and resource/ mining sectors, including raising or arranging equity funding (private equity, venture capital, pre IPO) as well as raising or arranging debt funding that fits your growth strategy.

Pre-revenue success strategies

For pre‑revenue companies, technology‑oriented milestones are the key inflection points for investors. We help you define and evidence those milestones, put in place the financial and governance infrastructure investors expect, and position your business for early‑stage equity capital raising, from seed through to pre‑Series rounds, including raising or arranging equity funding (private equity and venture capital) so you can fund continued R&D and commercialisation.

Pre-IPO advisory and preparation services

As you progress towards an IPO, we help you translate identified assets and growth plans into a compelling capital‑markets story. Our team works with an experienced C‑Suite and your advisors to shape your pre‑IPO equity raising, optimise your governance and reporting, and prepare you for life as a listed company, from prospectus through to post‑listing obligations.

Debt funding and capital structure support

We work alongside lenders, investors and your internal team to raise or arrange debt funding and structure growth‑oriented debt facilities that complement your equity capital. From working capital lines to acquisition and capex facilities, we help ensure your debt and equity capital raising sit within a coherent, flexible capital structure that supports your long‑term strategy.

Emerging listed company support

Companies emerge in rapid-investment sectors of the economy to capture opportunity ahead of social governance and legislative reforms—like the recent emergence of the Buy-Now-Pay-Later (BNPL) industry. We bring expertise and reliability for a solid foundation for companies emerging in the BioTech, Fintech and Resources industries—to reach their greatest potential.